carbostyril has been researched along with Atypical Mycobacterial Infection, Disseminated in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Aksu, K; Ateş, H; Başa Akdoğan, B; Çuhadar Erçelebi, D; Dedeoğlu, Ö; Koca Kalkan, İ; Köycü Buhari, G; Özkara, Ş; Türkyılmaz, S | 1 |
| Brown, S; Christiansen, N; Gomez-Pastrana, D; McLean, M; Nwokoro, C; Pao, CS | 1 |
| Balfour-Lynn, IM | 1 |
| Bostanabad, SZ; Feizabadi, MM; Hashemi Shahraki, A; Hashemzadeh, M; Heidarieh, P; Mirsaeidi, M; Nobar, MG | 1 |
| Dekio, S; Saito, H; Sato, K; Tomioka, H | 1 |
| Kevorkoff, G; Micheli, Z; Nigro, DR | 1 |
| Bourgeois, P; Cambau, E; Desplaces, N; Dion, E; Dubourg, G; Koeger, AC; Robin, H; Roche, B; Rozenberg, S; Vergeron, H | 1 |
| Kawahara, S; Nagare, H | 1 |
| Kamisaka, K; Kawahara, S; Kibata, M; Konishi, H; Matsuyama, T; Mishima, Y; Shiomi, K; Tada, A; Takeuchi, M; Yoshimoto, S | 1 |
| Hughes, KL; Studdert, VP | 1 |
| Zhang, TM | 1 |
3 review(s) available for carbostyril and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Clinical papers of the year 2018 - Cystic fibrosis.
Topics: Administration, Inhalation; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Azithromycin; Benzodioxoles; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Chloride Channel Agonists; Cough; Cross Infection; Cystic Fibrosis; Disease Progression; Drug Combinations; Drug Therapy, Combination; Humans; Indoles; Lung Transplantation; Microbiological Techniques; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nebulizers and Vaporizers; Proton Pump Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic; Specimen Handling; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
[Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Humans; Macrolides; Mycobacterium Infections, Nontuberculous; Quinolones; Rifamycins | 1998 |
[Advances in research on atypical mycobacterium infections].
Topics: Crohn Disease; Humans; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Quinolones | 1988 |
8 other study(ies) available for carbostyril and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
[Mycobacterium abscessus infection management: Macrolide and quinolone desensitization].
Topics: Anti-Bacterial Agents; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Quinolones | 2021 |
[Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation].
Topics: Adolescent; Aminophenols; Aspergillosis, Allergic Bronchopulmonary; Child; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genotype; Humans; Male; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nutritional Status; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 2019 |
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iran; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Tetracyclines | 2016 |
In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Spiro Compounds | 1994 |
[Treatment of non tuberculous mycobacteriosis with quinolones].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Quinolones | 1993 |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Discitis; Drug Therapy, Combination; Fluoroquinolones; Humans; Lumbar Vertebrae; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Sacrum | 1997 |
[A case of pulmonary atypical mycobacteriosis complicated with aplastic anemia, treated with surgical resection and postoperative sparfloxacin].
Topics: Anemia, Aplastic; Anti-Infective Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Quinolones; Tuberculosis, Pulmonary | 1992 |
Treatment of opportunistic mycobacterial infections with enrofloxacin in cats.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Enrofloxacin; Female; Fluoroquinolones; Male; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Quinolones; Skin Diseases, Infectious; Wound Infection | 1992 |